Article Cited by others

RESEARCH

Genistein chemoprevention of prostate cancer in TRAMP mice

Wang Jun, Eltoum Isam-Eldin, Lamartiniere Coral A

Year : 2007| Volume: 6| Issue : 1 | Page no: 3-3

   This article has been cited by
 
1 The strategies to control prostate cancer by chemoprevention approaches
Harold Ting,Gagan Deep,Chapla Agarwal,Rajesh Agarwal
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 Soy Isoflavones and Prostate Cancer: A Review of Molecular Mechanisms
Abeer M. Mahmoud,Wancai Yang,Maarten C. Bosland
The Journal of Steroid Biochemistry and Molecular Biology. 2013;
[Pubmed]  [Google Scholar] [DOI]
3 Future directions in the prevention of prostate cancer
Ian M. Thompson,April B. Cabang,Michael J. Wargovich
Nature Reviews Clinical Oncology. 2013; 11(1): 49
[Pubmed]  [Google Scholar] [DOI]
4 Soy Saponins Meditate the Progression of Colon Cancer in Rats by Inhibiting the Activity of ß-Glucuronidase and the Number of Aberrant Crypt Foci but Not Cyclooxygenase-2 Activity
Yu-Wei Guo,Yue-Hwa Chen,Wan-Chun Chiu,Hsiang Liao,Shyh-Hsiang Lin
ISRN Oncology. 2013; 2013: 1
[Pubmed]  [Google Scholar] [DOI]
5 Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer
Merrill J. Christensen,Trevor E. Quiner,Heather L. Nakken,Edwin D. Lephart,Dennis L. Eggett,Paul M. Urie
The Prostate. 2013; 73(9): 986
[Pubmed]  [Google Scholar] [DOI]
6 Progesterone as a morphological regulatory factor of the male and female gerbil prostate
Ricardo A. Fochi,Fernanda C. A. Santos,Rejane M. Goes,Sebastião R. Taboga
International Journal of Experimental Pathology. 2013; 94(6): 373
[Pubmed]  [Google Scholar] [DOI]
7 Effect of Germinated Soy Protein on the Growth of HeLa Cervical Cancer Cells in Female Athymic Mice
María del Carmen Robles-Ramírez,Eva Ramón-Gallegos,Francisco J. Reyes-Duarte,Rosalva Mora-Escobedo
Nutrition and Cancer. 2012; 64(8): 1261
[Pubmed]  [Google Scholar] [DOI]
8 Systemic Buffers Inhibit Carcinogenesis in TRAMP Mice
Arig Ibrahim-Hashim,Heather H. Cornnell,Dominique Abrahams,Mark Lloyd,Marilyn Bui,Robert J. Gillies,Robert A. Gatenby
The Journal of Urology. 2012; 188(2): 624
[Pubmed]  [Google Scholar] [DOI]
9 The mouse as a model to investigate sex steroid metabolism in the normal and pathological prostate
Keely McNamara, David Handelsman, Ulla Simanainen
The Journal of Steroid Biochemistry and Molecular Biology. 2011;
[HTML Full text]  [Google Scholar] [DOI]
10 The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells
Günter Vollmer, Janina Helle, Hakima Amri, Xunxian Liu, Julia T. Arnold
The Journal of Steroid Biochemistry and Molecular Biology. 2011;
[HTML Full text]  [Google Scholar] [DOI]
11 Effects of Commercially Available Soy Products on PSA in Androgen-Deprivation-Naïve and Castration-Resistant Prostate Cancer :
Monika Joshi, Nicole M. Agostino, Rebecca Gingrich, Joseph J. Drabick
Southern Medical Journal. 2011; 104(11): 736
[HTML Full text]  [Google Scholar] [DOI]
12 The Ron receptor promotes prostate tumor growth in the TRAMP mouse model
M N Thobe, J K Gray, D Gurusamy, A M Paluch, P K Wagh, P Pathrose, A B Lentsch, S E Waltz
Oncogene. 2011;
[HTML Full text]  [Google Scholar] [DOI]
13 The Prooxidant Action of Dietary Antioxidants Leading to Cellular DNA Breakage and Anticancer Effects: Implications for Chemotherapeutic Action Against Cancer
M. F. Ullah, Aamir Ahmad, Husain Y. Khan, H. Zubair, Fazlul H. Sarkar, S. M. Hadi
Cell Biochemistry and Biophysics. 2011;
[HTML Full text]  [Google Scholar] [DOI]
14 Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by Polymerase Chain Reaction arrays in human prostate cancer cell lines
Rabiau, N., Kossaï, M., Braud, M., Chalabi, N., Satih, S., Bignon, Y.-J., Bernard-Gallon, D.J.
Cancer Epidemiology. 2010; 34(2): 200-206
[Pubmed]  [Google Scholar]
15 Modeling prostate cancer: a perspective on transgenic mouse models
Varinder Jeet, Pamela J. Russell, Aparajita Khatri
Cancer and Metastasis Reviews. 2010; 29(1): 123-142
[Pubmed]  [Google Scholar] [DOI]
16 Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor
Hao Wang, Jiang Li, Yang Gao, Ying Xu, Ying Pan, Ichiro Tsuji, Zi-Jie Sun, Xiao-Meng Li
Asian Journal of Andrology. 2010; 12(4): 535
[HTML Full text]  [Google Scholar] [DOI]
17 Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by Polymerase Chain Reaction arrays in human prostate cancer cell lines
Nadège Rabiau,Myriam Kossaï,Martin Braud,Nasséra Chalabi,Samir Satih,Yves-Jean Bignon,Dominique J. Bernard-Gallon
Cancer Epidemiology. 2010; 34(2): 200
[Pubmed]  [Google Scholar] [DOI]
18 Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients
Srilatha Swami,Aruna V. Krishnan,Jacqueline Moreno,Rumi S. Bhattacharyya,Christopher Gardner,James D. Brooks,Donna M. Peehl,David Feldman
International Journal of Cancer. 2009; 124(9): 2050
[Pubmed]  [Google Scholar] [DOI]
19 Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats
Curt E. Harper,Leah M. Cook,Brijesh B. Patel,Jun Wang,Isam A. Eltoum,Ali Arabshahi,Tomoyuki Shirai,Coral A. Lamartiniere
The Prostate. 2009; 69(15): 1668
[Pubmed]  [Google Scholar] [DOI]
20 The Evolving Role of Oestrogens and Their Receptors in the Development and Progression of Prostate Cancer
Helmut Bonkhoff,Richard Berges
European Urology. 2009; 55(3): 533
[Pubmed]  [Google Scholar] [DOI]
21 Basal Cell Induced Differentiation of Noncancerous Prostate Epithelial Cells (RWPE-1) by Glycitein
Elizabeth A. Clubbs,Joshua A. Bomser
Nutrition and Cancer. 2009; 61(3): 390
[Pubmed]  [Google Scholar] [DOI]
22 Soy, isoflavones, and prostate cancer
Jian, L.
Molecular Nutrition \& Food Research. 2009; 53(2)
[Pubmed]  [Google Scholar]
23 Soy, isoflavones, and prostate cancer
Le Jian
Molecular Nutrition & Food Research. 2009; 53(2): 217
[Pubmed]  [Google Scholar] [DOI]
24 Antiseizure effects of 3a-androstanediol and/or 17ß-estradiol may involve actions at estrogen receptor ß
Cheryl A. Frye,Allicia Ryan,Madeline Rhodes
Epilepsy & Behavior. 2009; 16(3): 418
[Pubmed]  [Google Scholar] [DOI]
25 Cellular DNA breakage by soy isoflavone genistein and its methylated structural analogue biochanin A
Mohd Fahad Ullah, Uzma Shamim, Sarmad Hanif, Asfar S. Azmi, Sheikh M. Hadi
Molecular Nutrition & Food Research. 2009; 53(11): 1376
[HTML Full text]  [Google Scholar] [DOI]
26 Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway.
Morgan, TM and Koreckij, TD and Corey, E.
Current cancer drug targets. 2009; 9(2): 237-249
[Pubmed]  [Google Scholar]
27 Basal Cell Induced Differentiation of Noncancerous Prostate Epithelial Cells (RWPE-1) by Glycitein
Clubbs, E.A. and Bomser, J.A.
Nutrition and Cancer. 2009; 61(3): 390-396
[Pubmed]  [Google Scholar]
28 Characterization of SV-40 Tag rats as a model to study prostate cancer
Harper, C.E. and Patel, B.B. and Cook, L.M. and Wang, J. and Shirai, T. and Eltoum, I.A. and Lamartiniere, C.A.
BMC cancer. 2009; 9(1): 30
[Pubmed]  [Google Scholar]
29 The role of murine models of prostate cancer in drug target discovery and validation
Ahmad, I., Sansom, O.J., Leung, H.Y.
Expert Opinion on Drug Discovery. 2009; 4(8): 879-888
[Pubmed]  [Google Scholar]
30 Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients
Swami, S., Krishnan, A.V., Moreno, J., Bhattacharyya, R.S., Gardner, C., Brooks, J.D., Peehl, D.M., Feldman, D.
International Journal of Cancer. 2009; 124(9): 2050-2059
[Pubmed]  [Google Scholar]
31 The Evolving Role of Oestrogens and Their Receptors in the Development and Progression of Prostate Cancer
Bonkhoff, H., Berges, R.
European Urology. 2009; 55(3): 533-542
[Pubmed]  [Google Scholar]
32 Using nanotechnology to improve the water solubility and bioavailability of health care products-soy isoflavones
Xu, J.J., Luo, K.Q.
AIChE Annual Meeting, Conference Proceedings. 2009;
[Pubmed]  [Google Scholar]
33 Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats
Harper, C.E., Cook, L.M., Patel, B.B., Wang, J., Eltoum, I.A., Arabshahi, A., Shirai, T., Lamartiniere, C.A.
Prostate. 2009; 69(15): 1668-1682
[Pubmed]  [Google Scholar]
34 Antiseizure effects of 3α-androstanediol and/or 17β-estradiol may involve actions at estrogen receptor β
Frye, C.A., Ryan, A., Rhodes, M.
Epilepsy and Behavior. 2009; 16(3): 418-422
[Pubmed]  [Google Scholar]
35 A comparative study on different characteristics between prostate cancer model and BPH model of BALB/c mice
Weigui, S., Yiping, G., Zhangqun, Y., Qiangguo, Y., Zhenguo, M., Xiaosong, S., Zhaoyin, F., Chunzhi, H.
Gene Therapy and Molecular Biology. 2009; 13(1): 205-213
[Pubmed]  [Google Scholar]
36 Potentiation of the Growth-Inhibitory Effects of Vitamin D in Prostate Cancer by Genistein
Aruna V. Krishnan, Srilatha Swami, Jacqueline Moreno, Rumi B. Bhattacharyya, Donna M. Peehl, David Feldman
Nutrition Reviews. 2008; 65: S121
[HTML Full text]  [Google Scholar] [DOI]
37 An improved and more simplified benign prostatic hyperplasia mice model and its characteristics
Sun, W., Ye, Z., Mi, Z., Wang, Q., Ren, L., Wang, H.
Chinese Journal of Andrology. 2008; 22(1): 24-27
[Pubmed]  [Google Scholar]
38 Downregulation of IgG Fc binding protein (FcγBP) in prostate cancer
Gazi, M.H., He, M., Cheville, J.C., Young, C.Y.F.
Cancer Biology and Therapy. 2008; 7(1): 70-75
[Pubmed]  [Google Scholar]
39 Comparative expression analysis of sex hormone, VEGF, bFGF and PSA in prostate cancer cells LNCap and DU145 in vitro
Sun, W., Gan, Y., Yu, Q., Song, X., Fan, Y., Ye, Z., Mi, Z., (...), Han, C.
Chinese Journal of Andrology. 2008; 22(11): 5-8-16
[Pubmed]  [Google Scholar]
40 Advances in mouse models of prostate cancer
Ahmad, I. and Sansom, O.J. and Leung, H.Y.
Expert Reviews in Molecular Medicine. 2008; 10(16)
[Pubmed]  [Google Scholar]
41 Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise
Naghma Khan, Farrukh Afaq, Hasan Mukhtar
Antioxidants and Redox Signaling. 2008; 10(3): 475
[HTML Full text]  [Google Scholar] [DOI]
42 Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics
Steiner, C. and Arnould, S. and Scalbert, A. and Manach, C.
British Journal of Nutrition. 2008; 99(E-S1): ES78-ES108
[Pubmed]  [Google Scholar]
43 Use of natural products in anti-cancer alternative therapy: risk of interactions with conventional anti-cancer drugs
RODEIRO, I. and MARGARI{\~N
Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas. 2008; 7(6): 332
[Pubmed]  [Google Scholar]
44 Dietary Phytochemicals in the Chemoprevention of Prostate Cancer
Khan, N. and Adhami, V.M. and Afaq, F. and Mukhtar, H.
Polyphenols and Health: New and Recent Advances. 2008; : 221
[Pubmed]  [Google Scholar]
45 Comprehensive Invited Review
KHAN, N. and AFAQ, F. and MUKHTAR, H.
ANTIOXIDANTS \& REDOX SIGNALING. 2008; 10(3): 475-510
[Pubmed]  [Google Scholar]
46 The Evolving Role of Oestrogens and Their Receptors in the Development and Progression of Prostate Cancer
Bonkhoff, H. and Berges, R.
European Urology. 2008;
[Pubmed]  [Google Scholar]
47 Prevention of Prostate Cancer: What We Know and Where We Are Going
Jayachandran, J. and Freedland, S.J.
American Journal of Menæs Health. 2008; 2(2): 178
[Pubmed]  [Google Scholar]
48 Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics
Claudia Steiner,Stéphanie Arnould,Augustin Scalbert,Claudine Manach
British Journal of Nutrition. 2008; 99(E-S1)
[Pubmed]  [Google Scholar] [DOI]
49 Advances in mouse models of prostate cancer
Imran Ahmad,Owen J. Sansom,Hing Y. Leung
Expert Reviews in Molecular Medicine. 2008; 10
[Pubmed]  [Google Scholar] [DOI]
50 Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: Mechanisms of action
Curt E. Harper,Brijesh B. Patel,Jun Wang,Isam A. Eltoum,Coral A. Lamartiniere
The Prostate. 2007; 67(14): 1576
[Pubmed]  [Google Scholar] [DOI]
51 Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health
Filippos Ververidis,Emmanouil Trantas,Carl Douglas,Guenter Vollmer,Georg Kretzschmar,Nickolas Panopoulos
Biotechnology Journal. 2007; 2(10): 1214
[Pubmed]  [Google Scholar] [DOI]
52 Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health
Ververidis, F. and Trantas, E. and Douglas, C. and Vollmer, G. and Kretzschmar, G. and Panopoulos, N.
BIOTECHNOLOGY JOURNAL. 2007; 2(10): 1214
[Pubmed]  [Google Scholar]
53 Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signaling
Risbridger, G.P. and Ellem, S.J. and McPherson, S.J.
Journal of Molecular Endocrinology. 2007; 39(3): 183
[Pubmed]  [Google Scholar]
54 Epigallocatechin-3-gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action
Harper, C.E. and Patel, B.B. and Wang, J. and Eltoum, I.A. and Lamartiniere, C.A.
The Prostate. 2007; 67(14): 1576-1589
[Pubmed]  [Google Scholar]
55 Molecular mechanisms of apoptosis in prostate cancer
Lorenzo, P.I., Arnoldussen, Y.J., Saatcioglu, F.
Critical Reviews in Oncogenesis. 2007; 13(1): 1-38
[Pubmed]  [Google Scholar]

 

Read this article